These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 19272067)

  • 21. OptiVol fluid status monitoring with an implantable cardiac device: a heart failure management system.
    Yamokoski LM; Haas GJ; Gans B; Abraham WT
    Expert Rev Med Devices; 2007 Nov; 4(6):775-80. PubMed ID: 18035943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac resynchronization therapy reduces the risk of hospitalizations in patients with advanced heart failure: results from the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) trial.
    Anand IS; Carson P; Galle E; Song R; Boehmer J; Ghali JK; Jaski B; Lindenfeld J; O'Connor C; Steinberg JS; Leigh J; Yong P; Kosorok MR; Feldman AM; DeMets D; Bristow MR
    Circulation; 2009 Feb; 119(7):969-77. PubMed ID: 19204305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hospital variation and characteristics of implantable cardioverter-defibrillator use in patients with heart failure: data from the GWTG-HF (Get With The Guidelines-Heart Failure) registry.
    Shah B; Hernandez AF; Liang L; Al-Khatib SM; Yancy CW; Fonarow GC; Peterson ED;
    J Am Coll Cardiol; 2009 Feb; 53(5):416-22. PubMed ID: 19179199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary fluid overload monitoring in heart failure patients with single and dual chamber defibrillators.
    Molon G; Zanotto G; Rahue W; Facchin D; Leoni L; Morani G; Calvi V; Catanzariti D; Costa A; Zago L; Comisso J; Varbaro A; Santini M
    J Cardiovasc Med (Hagerstown); 2014 Apr; 15(4):307-14. PubMed ID: 24698971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prognostic index relating 24-hour ambulatory blood pressure to cardiac events in ischemic cardiomyopathy following defibrillator implantation.
    Antonini L; Colivicchi F; Pasceri V; Greco S; Varveri A; Turani L; Kol A; Santini M
    Pacing Clin Electrophysiol; 2008 Sep; 31(9):1089-94. PubMed ID: 18834457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implantable cardioverter defibrillators: do women fare worse than men? Gender comparison in the INTRINSIC RV trial.
    Russo AM; Day JD; Stolen K; Mullin CM; Doraiswamy V; Lerew DL; Olshansky B
    J Cardiovasc Electrophysiol; 2009 Sep; 20(9):973-8. PubMed ID: 19470037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dual-chamber implantable cardioverter defibrillators reduce clinical adverse events related to atrial fibrillation when compared with single-chamber defibrillators: a subanalysis of the DATAS trial.
    Ricci RP; Quesada A; Almendral J; Arribas F; Wolpert C; Adragao P; Zoni-Berisso M; Navarro X; DeSanto T; Grammatico A; Santini M;
    Europace; 2009 May; 11(5):587-93. PubMed ID: 19401341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of different device-based intrathoracic impedance vectors for detection of heart failure events (from the Detect Fluid Early from Intrathoracic Impedance Monitoring study).
    Heist EK; Herre JM; Binkley PF; Van Bakel AB; Porterfield JG; Porterfield LM; Qu F; Turkel M; Pavri BB;
    Am J Cardiol; 2014 Oct; 114(8):1249-56. PubMed ID: 25150135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study.
    Bourge RC; Abraham WT; Adamson PB; Aaron MF; Aranda JM; Magalski A; Zile MR; Smith AL; Smart FW; O'Shaughnessy MA; Jessup ML; Sparks B; Naftel DL; Stevenson LW;
    J Am Coll Cardiol; 2008 Mar; 51(11):1073-9. PubMed ID: 18342224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual-chamber defibrillators reduce clinically significant adverse events compared with single-chamber devices: results from the DATAS (Dual chamber and Atrial Tachyarrhythmias Adverse events Study) trial.
    Almendral J; Arribas F; Wolpert C; Ricci R; Adragao P; Cobo E; Navarro X; Quesada A; ; ;
    Europace; 2008 May; 10(5):528-35. PubMed ID: 18390985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship of paroxysmal atrial tachyarrhythmias to volume overload: assessment by implanted transpulmonary impedance monitoring.
    Jhanjee R; Templeton GA; Sattiraju S; Nguyen J; Sakaguchi S; Lu F; Ermis C; Milstein S; Van Heel L; Lurie KG; Benditt DG
    Circ Arrhythm Electrophysiol; 2009 Oct; 2(5):488-94. PubMed ID: 19843916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Device monitoring of heart failure in cardiac resynchronization therapy device recipients: a single-center experience with a novel multivector impedance monitoring system.
    Forleo GB; Panattoni G; Schirripa V; Papavasileiou LP; Della Rocca DG; Politano A; Ticconi F; Biscione C; Sergi D; Di Molfetta A; Santini L; Capria A; Romeo F
    J Cardiovasc Med (Hagerstown); 2013 Oct; 14(10):726-32. PubMed ID: 23996011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ambulatory respiratory rate trends identify patients at higher risk of worsening heart failure in implantable cardioverter defibrillator and biventricular device recipients: a novel ambulatory parameter to optimize heart failure management.
    Goetze S; Zhang Y; An Q; Averina V; Lambiase P; Schilling R; Trappe HJ; Winter S; Wold N; Manola L; Kestens D
    J Interv Card Electrophysiol; 2015 Jun; 43(1):21-9. PubMed ID: 25863797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experience with implantable cardioverter-defibrillator therapy in grown-ups with congenital heart disease.
    Tomaske M; Bauersfeld U
    Pacing Clin Electrophysiol; 2008 Feb; 31 Suppl 1():S35-7. PubMed ID: 18226033
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integration of automatic intrathoracic fluid content measurement into clinical decision making in patients with congestive heart failure.
    Knackstedt C; Mischke K; Schimpf T; Waringer J; Fache K; Frechen D; Gramley F; Kelm M; Schauerte P
    Pacing Clin Electrophysiol; 2008 Aug; 31(8):961-7. PubMed ID: 18684251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patient Alert to detect ICD lead failure: efficacy, limitations, and implications for future algorithms.
    Vollmann D; Erdogan A; Himmrich E; Neuzner J; Becker D; Unterberg-Buchwald C; Sperzel J
    Europace; 2006 May; 8(5):371-6. PubMed ID: 16635998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Competing risk analysis of cause-specific mortality in patients with an implantable cardioverter-defibrillator: The EVADEF cohort study.
    Marijon E; Trinquart L; Otmani A; Waintraub X; Kacet S; Clémenty J; Chatellier G; Le Heuzey JY;
    Am Heart J; 2009 Feb; 157(2):391-397.e1. PubMed ID: 19185651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The lung impedance monitoring in treatment of chronic heart failure (the LIMIT-CHF study).
    Domenichini G; Rahneva T; Diab IG; Dhillon OS; Campbell NG; Finlay MC; Baker V; Hunter RJ; Earley MJ; Schilling RJ
    Europace; 2016 Mar; 18(3):428-35. PubMed ID: 26683599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Technical and practical aspects of remote monitoring of implantable cardioverter-defibrillator patients in Poland - preliminary results.
    Przybylski A; Zakrzewska-Koperska J; Maciag A; Derejko P; Orczykowski M; Szumowski L; Walczak F
    Kardiol Pol; 2009 May; 67(5):505-11. PubMed ID: 19521935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atrial tachyarrhythmias temporally precede fluid accumulation in implantable device patients.
    Andriulli JA; Moore HJ; Hettrick DA; Ousdigian KT; Johnson J; Markowitz SM
    Pacing Clin Electrophysiol; 2014 May; 37(5):554-61. PubMed ID: 24341570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.